SIMS Hospital successfully treats rare skin tumour with skull and scalp reconstruction
The patient had been battling DFSP for over eight years, enduring multiple recurrences despite three previous surgeries
The patient had been battling DFSP for over eight years, enduring multiple recurrences despite three previous surgeries
Star Health Insurance is modernising its claims ecosystem to be future-ready
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
Access to NIPT, TB and Rare Disease diagnostics to benefit thousands of patients nationwide
Arth by Emcure is a specialized range of supplements designed to address the unique health and wellness needs of women, enabling them to lead healthier and happier lives across all stages
Based on ECHO Phase III trial results which showed more than 16 months of progression-free survival improvement vs. chemoimmunotherapy alone
Based on ECHO Phase III trial which demonstrated Calquence combination reduced risk of disease progression or death by 27% compared to standard-of-care chemoimmunotherapy
Subscribe To Our Newsletter & Stay Updated